The binding of the CD4 receptor by the human immunodeficiency virus type 1 gpl20 exterior envelope glycoprotein is important for virus entry and cytopathic effect. To investigate the CD4-binding region of the gpl20 glycoprotein, we altered gpl20 amino acids, excluding cysteines, that are conserved among the primate immunodeficiency viruses utilizing the CD4 receptor. Changes in two hydrophobic regions (Thr-257 in conserved region 2 and Trp-427 in conserved region 4) and two hydrophilic regions (Asp-368 and Glu-370 in conserved region 3 and Asp-457 in conserved region 4) resulted in significant reductions in CD4 binding. For most of the mutations affecting these residues, the observed effects on CD4 binding did not apparently result from global conformational disruption of the gpl20 molecule, as assessed by measurements of precursor processing, subunit association, and monoclonal antibody recognition. The two hydrophilic regions exhibit a strong propensity for ,8-turn formation, are predicted to act as efficient B-cell epitopes, and are located adjacent to hypervariable, glycosylated regions. This study defines a small number of gpl20 residues important for CD4 binding, some of which might constitute attractive targets for immunologic intervention.
Human immunodeficiency virus type 1 (HIV-1) is the etiologic agent of acquired immune deficiency syndrome (4, 12, 30) , which is characterized by depletion of CD4-positive lymphocytes (13, 21) . The tropism of HIV-1 for CD4-positive cells is due to a specific interaction between CD4, the viral receptor, and the gpl20 exterior envelope glycoprotein (10, 16, 17, 24) . After receptor binding, the viral envelope glycoproteins gpl20 and gp4l mediate the fusion of the viral and host cell membranes to allow viral entry (33) . The gp120 and gp4l glycoproteins are derived from the cleavage of a gpl6Q envelope glycoprotein precursor and are held together by noncovalent interactions (1, 18, 31) .
Insertions or deletions in conserved gpl20 regions Cl, C3, C4, and C5 have been shown to affect CD4 binding (7, 8, 18, 22, 23, 35) , although the effect of these changes on gpl20 conformation was not examined. A proteolytic fragment composed of the 160 carboxy-terminal gpl20 residues has been reported to bind CD4 (28) , and antibodies directed against C4 or C5 could block CD4 binding in some circumstances (2, 11, 22, 34) . To define the CD4-binding region more precisely, we altered gpl20 amino acids, excluding cysteines, that are conserved among the primate immunodeficiency viruses utilizing the CD4 receptor (27) . We examined the processing of the gpl60 precursor, the association of the gpl20 and gp4l glycoproteins, and recognition of the mutant gp120 molecules by monoclonal antibodies to assess the potential effects of the introduced changes on gpl20 conformation. The results define four gpl20 regions that are critical for the interaction with CD4. Two of the regions are predicted to be exposed on the native molecule and therefore might constitute attractive targets for immunologic intervention.
MATERIALS AND METHODS Construction of plasmids expressing mutant envelope glycoproteins. The KpnI-BamHI fragment of the pSVIIIenv plas-* Corresponding author. mid (14) was used for site-directed mutagenesis by the procedure of Kunkel et al. (19) . The presence of the mutation was confirmed by the generation of a novel restriction endonuclease site in some cases and by DNA sequencing (32) . Two independent clones of each mutated env fragment were prepared and used for the CD4 binding assay to ensure that spontaneous mutations distant from the desired mutation were not responsible for the observed phenotypes. HIV-2, simian immunodeficiency virus SIVmac, and SIVagm gpl20 exterior envelope glycoproteins (27, 36) . The mutated env gene of the HXBc2 HIV-1 strain was cloned into the pSVIIIenv plasmid, which allows a high level of transient expression of the gpl60 envelope precursor in transfected COS-1 cells (14) . For gpl60 mutants that undergo proteolytic cleavage, the mature gpl20 exterior envelope glycoprotein can be detected in supernatants of transfected COS-1 cells, due to the lability of gpl20 association with the gp4l transmembrane glycoprotein (14, 18) . Radiolabeled gpl20 present in transfected COS-1 cell supernatants was used to assess the ability to bind to the CD4 molecule on the surface of SupTl lymphocytes. All the CD4 binding experiments were performed under conditions in which the CD4 concentration was not limiting for gpl20 binding (data not shown) so that the calculated relative binding ability approximated the true ratio of the mutant/wild-type binding constants. Pilot experiments indicated that, over a greater than 20-fold range of total gpl20 concentrations, the ratio of bound/free gpl20 did not vary for the wild-type glycoprotein (data not shown). Figure 1A shows several examples of the results, which were used to calculate the CD4-binding abilities of the mutant gpl20 glycoproteins (Table 1 and Fig. 1B) . With nine exceptions, all the mutant envelope glycoproteins were processed to gpl20 molecules detected in the COS-1 cell supernatants. Even though most of the introduced amino acid changes were not conservative, the majority of gpl20 mutants exhibited CD4-binding ability that did not differ more than twofold from that of the wild-type glycoprotein. These results indicate that the majority of well-conserved gpl20 residues are not, per se, essential for high-affinity CD4 binding.
Measurement
Substitution mutations affecting 12 gpl20 residues resulted in glycoproteins that exhibited less than 50% of the CD4-binding ability of the wild-type gpl20. The effects of the introduced changes on the processing of the gpl60 precursor, the association of the gpl20 molecule with the gp4l glycoprotein on the expressing cell, and the ability of three mouse monoclonal antibodies (HAl, HA2, and HT2) that recognize conformation-dependent gpl20 epitopes (David .1II (Table 2 and data not shown). Conversion of threonine 257 to arginine reduced CD4-binding ability by 84%, whereas more conservative changes to alanine or glycine resulted in a gpl20 protein with nearly wild-type binding ability. These results indicate that some amino acid changes in this residue can dramatically disrupt CD4 binding, although the presence of threonine at position 257 is not indispensable for CD4 binding.
Some changes in the acidic residues in two regions of the gpl20 glycoprotein, Asp-368/Glu-370 and Asp-457, resulted in marked reduction in CD4 binding. Complete loss of detectable CD4 binding was associated with conversion of residue 368 or 370 to a positively charged amino acid (368 D/R, 368 D/K, and 370 E/R). Decreases in binding affinity were noted for other changes in these residues, even for relatively conservative changes (368 D/E, 368 D/N, 370 E/D, and 370 E/Q).
DISCUSSION
Of the gpl20 amino acids conserved among primate immunodeficiency viruses, alterations in five residues exhibited significant effects on CD4-binding ability that could not be easily attributed to gross conformational changes in the mutant gpl20 proteins. First, we studied gpl20 molecules derived from gpl60 precursor proteins that had undergone proteolytic cleavage and transport to the cell surface, processes that are known to select strongly for correctly folded glycoproteins. Such constraints on transport appear to be far less restrictive when truncated soluble forms of gpl20 are made (11, 18 ; M. Kowalski and J. Sodroski, unpublished observations). Second, most of the gpl20 mutants markedly reduced for CD4 binding still associated with the expressing cell, an interaction dependent on the gp4l exterior domain (18) as well as on discontinuous regions located at both the amino and carboxy termini of gpl20 (E. Helseth, U. 01-shevsky, and J. Sodroski, unpublished data). Third, reactivity of the gpl20 mutants that exhibited diminished CD4 binding with three monoclonal antibodies that recognize conformationally dependent gpl20 epitopes was maintained, although this parameter was insensitive to gpl20 structural changes relative to precursor processing or cell association.
Of the five gpl20 amino acids identified in this study as important for CD4 binding, three (Asp-368, Glu-370, and Asp-457) are located in hydrophilic regions within the proteolytic fragment reported to retain CD4-binding ability (28) . Sequence comparison of primate immunodeficiency viruses (27) indicates that the presence of a carbonyl group, rather than the acidic group, in the side chain of residue 457 is a conserved feature (Fig. 2) . While surrounding residues exhibit moderate variability, amino acids 368 and 370 are invariant in all viruses, except for SIVMND, in which a glutamic acid is positioned two residues carboxy terminal to the 370 position (35) . The alteration of either the position 368 or 370 acidic side chain to a basic side chain is especially disruptive of CD4-binding ability. This result suggests that the presence of a charged residue in these positions is not sufficient for CD4 binding and raises the possibility that the acidic side chains participate in ionic bonds, either with CD4 or with other gpl20 regions. It is noteworthy that the CD4 region important for gpl20 binding (3, 5, 6, 15, 20, 25, 29) contains several basic residues that might require neutralization by acidic amino acids to stabilize the gpl20-CD4 interaction.
The 368, 370, and 457 residues, although distant on the linear gpl20 sequence, may be proximal on the native molecule. This model, supported by the recent observation that the gpl20 cysteine residues at positions 378 and 445 are disulfide linked (22a), suggests that these two regions form a symmetrical structure (Fig. 3) (Fig. 3) .
Antibodies directed against the hydrophobic gpl20 region encompassing residues 423 to 438 interfere with CD4 binding (11, 22, 34 efficiently associate with the gp4l transmembrane glycoprotein, suggesting that at least local conformational effects result from the mutations.
One mutation affecting gpl20 residue 257, which is not contained within the gpl20 proteolytic fragment reported to but physically proximal to the CD4-binding region can diminish binding affinity. Alternatively, the region near Thr-257, as well as that near Trp-427, may contribute to hydrophobic interactions between gpl20 and CD4. Further analysis will be required to distinguish which if any of the small group of gpl20 amino acids identified as important for CD4 binding by mutagenesis directly interacts with CD4.
